Riccardo Soffietti

Turin, Italy
  • Professor of Neurology and Neuro-Oncology, University of Torino, Medical School
  • Head, Dept. Neuro-Oncology, University and City of Health and Science University Hospital of Turin, Italy.
  • Founding Member and President of European Association of Neuro-Oncology (EANO) (from 2012 to 2014)
  • Member of the Education Committee of European Cancer Organization (ECCO)
  • Member of the Congress Program Committee of the European Academy of Neurology (EAN)
  • Chair of the Subspecialty Scientific Panel of Neuro-Oncology of EAN
  • Member of the Steering Committee of the Brain Tumor Group of the European Organization for Research and Treatment of Cancer ( EORTC )
  • Coordinator of the EORTC study n° 22952-26001 (Phase III) "No radiotherapy versus whole brain radiotherapy for 1 to 3 brain metastases from solid tumor after surgical resection or radiosurgery".
  • Chairman of the Research Group for Neuro-Oncology of the World Federation of Neurology
  • Cancer Expertise for research projects of the European Community and of Ministry of Health and Research of Italy, France, Switzerland and Netherlands.
  • Advisor of the European Medicines Agency (EMA).
  • Member of the International Group on Response Assessment in Neuro-Oncology (RANO).
  • 350 publications (including full papers, chapters in books, monographies, abstracts of International Congresses).
  • Executive Editor of Neuro-Oncology
  • Member of the Editorial Board : Neuro-Oncology Practice, Anticancer Drugs, Journal of Neurology, Current Cancer Therapy Reviews, CNS Oncology and Neurological Sciences.
  • Referee: Neurology, Lancet Neurology, Brain, European Journal of Neurology, Lancet, Lancet Oncology, Journal of Clinical Oncology, Clinical Cancer Research, Cancer, European Journal of Cancer, The Oncologist, Journal of Neuro-Oncology, Critical Review in Hematology and Oncology, Expert Opinion on Pharmacotherapy, Oncology Research, Tumori, Expert Review of Neurotherapeutics, Expert Review of Anticancer Therapy, Future Oncology, British Medical Cancer Journal.
  • Award for Excellence in Clinical Research (Society for Neuro-Oncology, US, 2009)